z-logo
Premium
High‐dose tamoxifen and sulindac as first‐line treatment for desmoid tumors
Author(s) -
Sturt N. Julian H.,
Phillips Robin K. S.,
Clark Susan K.
Publication year - 2004
Publication title -
cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.052
H-Index - 304
eISSN - 1097-0142
pISSN - 0008-543X
DOI - 10.1002/cncr.20416
Subject(s) - familial adenomatous polyposis , medicine , tamoxifen , sulindac , adenomatous polyposis coli , germline mutation , disease , fibromatosis , germline , oncology , cancer , gastroenterology , colorectal cancer , pathology , mutation , gene , breast cancer , biochemistry , chemistry , nonsteroidal

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom